Senior Director – Late-Stage Cell Therapy Process Development

Sana Biotechnology, Inc.

Cambridge (MA)

On-site

USD 250,000 - 300,000

Full time

14 days+

Get more replies from employers

Send a job-specific resume in minutes.

Job summary

Sana Biotechnology, Inc. is hiring a Senior Director for Late-Stage Cell Therapy Process Development in Cambridge, MA. You'll oversee the development of manufacturing processes for PSC-derived islet products aimed at treating Type 1 diabetes.

The role involves managing a team, ensuring compliance with regulatory standards, and leading process validation activities. Ideal candidates should have a Ph.D. and extensive experience in cell therapy.

Qualifications

  • Minimum of 10 years experience in cell therapy process development, with >5 years in a leadership role.
  • Hands-on experience with various bioreactor systems.
  • Knowledge of stem cell biology and GMP manufacturing.

Responsibilities

  • Develop late-stage cell therapy processes ensuring scalability and quality.
  • Lead process characterization activities and validation.
  • Mentor and develop a high-performing team.

Skills

Experience in cell therapy process development
Leadership in late stage development
Knowledge of cGMP
Excellent communication skills

Education

Ph.D. in Biochemical Engineering or Chemical Engineering

Tools

Bioreactor systems
Analytical tools for media evaluation

Job description

Sana Biotechnology, Inc. is hiring a Senior Director for Late-Stage Cell Therapy Process Development in Cambridge, MA. You'll oversee the development of manufacturing processes for PSC-derived islet products aimed at treating Type 1 diabetes.

The role involves managing a team, ensuring compliance with regulatory standards, and leading process validation activities. Ideal candidates should have a Ph.D. and extensive experience in cell therapy.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Senior Director, Late Stage Cell Therapy Process Development
Senior Director, Late Stage Cell Therapy Process Development

Sana Biotechnology, Inc. • Cambridge (MA)

On-site
USD 250,000 - 300,000
Senior Director, Cell Therapy Process Development (Hybrid)
Senior Director, Cell Therapy Process Development (Hybrid)

AstraZeneca • Santa Monica (CA)

Hybrid
USD 138,000 - 207,000
Short-term incentives
Equity awards
Retirement plan
+2
Senior Scientist, 3D PSC Islet Bioprocessing
Senior Scientist, 3D PSC Islet Bioprocessing

Sana Biotechnology, Inc. • Cambridge (MA)

On-site
USD 160,000 - 190,000
Paid time off
Health insurance
401(k) with employer match
+1
Lead Cell Therapy Process Development Scientist
Lead Cell Therapy Process Development Scientist

Vertex Pharmaceuticals LLC • Boston (MA), Northern (KY)

Hybrid
USD 104,000 - 156,000
Annual bonus
Equity awards
Paid time off
+2
Senior Director, Biotech Business Development Partnerships
Senior Director, Biotech Business Development Partnerships

Sana Biotechnology, Inc. • Cambridge (MA), Northern (KY)

Hybrid
USD 250,000 - 315,000
Senior Scientist, Cell Therapy Islet
Senior Scientist, Cell Therapy Islet

Sana Biotechnology, Inc. • Cambridge (MA)

On-site
USD 160,000 - 190,000
Paid time off
Health insurance
401(k) with employer match
+1
Senior Scientist, Process Development - Cell Therapy
Senior Scientist, Process Development - Cell Therapy

Cedent • Watertown (MA)

On-site
USD 90,000 - 120,000
Lead Cell Therapy Process Development Scientist
Lead Cell Therapy Process Development Scientist

Vertex Pharmaceuticals • Boston (MA)

On-site
USD 104,000 - 156,000
Annual bonus
Equity awards
Comprehensive benefits
Senior Scientist, Cell Therapy Process Scale-Up
Senior Scientist, Cell Therapy Process Scale-Up

Sanofi • Waltham (MA)

On-site
USD 100,000 - 130,000
Health and wellbeing benefits
14 weeks gender-neutral parental leave
Director, Bioprocess & Process Development - Lead & Scale-Up
Director, Bioprocess & Process Development - Lead & Scale-Up

BioSpace • Cambridge (MA)

On-site
USD 180,000 - 260,000
Comprehensive benefits
Discretionary bonus
Stock-based incentives
+1